Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Proteomics|November 28, 2001
Contribution of proteomics to tumor immunologyF Le Naour
Science (New York, N.Y.)|January 15, 2000
Severely reduced female fertility in CD9-deficient miceF Le Naour, E Rubinstein, C Jasmin, et al.
European Journal of Immunology|December 1, 1994
CD9 antigen is an accessory subunit of the VLA integrin complexesE Rubinstein, F Le Naour, M Billard, et al.
Cancer Research|November 3, 2001
Proteomics-based identification of protein gene product 9.5 as a tumor antigen that induces a humoral immune response in lung cancerF Brichory, D Beer, F Le Naour, et al.
Thrombosis and Haemostasis|July 15, 2000
CD9 gene deficiency does not affect smooth muscle cell migration and neointima formation after vascular injury in miceH R Lijnen, F Lupu, D Collen, et al.
European Journal of Immunology|August 1, 1997
CD9, but not other tetraspans, associates with the beta1 integrin precursorE Rubinstein, V Poindessous-Jazat, F Le Naour, et al.
Oncogene|August 1, 1996
Transcriptional regulation of the human CD9 gene: characterization of the 5'-flanking regionF Le Naour, M Prenant, C Francastel, et al.
Leukemia|August 1, 1997
Upregulation of CD9 expression during TPA treatment of K562 cellsF Le Naour, C Francastel, M Prenant, et al.
European Journal of Immunology|November 1, 1996
CD9, CD63, CD81, and CD82 are components of a surface tetraspan network connected to HLA-DR and VLA integrinsE Rubinstein, F Le Naour, C Lagaudrière-Gesbert, et al.
The Biochemical Journal|May 7, 1999
Selective tetraspan-integrin complexes (CD81/alpha4beta1, CD151/alpha3beta1, CD151/alpha6beta1) under conditions disrupting tetraspan interactionsV Serru, F Le Naour, M Billard, et al.
Pageof 2